U.S. Generic Pharmaceutical Manufacturing Market Report 2024: Size, Industry Analysis, Trends and Forecasts to 2029 Featuring Profiles of Teva Pharmaceutical Industries, Mylan, Hospira & More
October 16, 2024 07:52 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Generic Pharmaceutical Manufacturing in the US - Market Size, Industry Analysis, Trends and Forecasts (2024-2029)" report has been added to ...
Saudi Arabia Generic Pharmaceutical Products Market Report 2024-2031, Featuring Profiles of Key Players - Jamjoom Pharma, Pfizer, Hikma Pharma, Fresenius, Novartis & More
October 16, 2024 04:55 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Saudi Arabia Generic Pharmaceutical Products Market by Type, Application, Route of Administration, End User, and Distribution Channel: Market Size,...
Generic Drugs Market Report 2024-2034: Patent Expiration of Blockbuster Drugs in this Decade and Growth of Biologics and Biosimilars Fueling Opportunities
July 01, 2024 10:22 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Generic Drugs Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.Overall world revenue for Generic Drugs Market, 2024...
US Generic Drug Industry Research 2024-2032: $124 Billion Market Analysis by Segment, Therapy Area, Drug Delivery, & Distribution Channel
May 20, 2024 10:20 ET
|
Research and Markets
Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "US Generic Drug Market Report by Segment, Therapy Area, Drug Delivery, Distribution Channel 2024-2032" report has been added to ...
United States Generic Drugs Market Research Report 2023-2028 - Rise In the Number of Generic Drug Approvals
December 12, 2023 11:23 ET
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "United States Generic Drugs Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
Global Generic Drugs (Small Molecule Generics vs Biosimilars) Market 2018-2028: Key Players Include Teva, Sandoz, Viatris, Sun Pharma, and Others
August 07, 2023 09:03 ET
|
Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Generic Drugs Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2018-2028F By Type (Small Molecule Generics vs Biosimilars), By...
United States Generic Drugs Market Forecast Report 2023: A $147.57 Billion Market by 2028 from $101 Billion in 2022 - Increasing Prevalence of Life-threatening Diseases Creating Opportunities
May 10, 2023 10:18 ET
|
Research and Markets
Dublin, May 10, 2023 (GLOBE NEWSWIRE) -- The "United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis" report has been added...
Outlook on the Branded Generics Global Market to 2028 - Featuring Par Pharmaceuticals, Sandoz International, Aspen Holdings and Hetero Among Others
September 23, 2022 04:53 ET
|
Research and Markets
Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) -- The "Branded Generics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Therapeutic Application, Distribution Channel, Drug Class, and...
United States Generic Drugs Market Report 2021: Small Molecule Generics v/s Biosimilars - Forecast to 2026
February 07, 2022 05:23 ET
|
Research and Markets
Dublin, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The "United States Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Application, By Mode of Drug Delivery, By Form, By Source, By...
Global Generic Drugs (Small Molecule Generics vs Biosimilars) Markets Report 2021: Market was Valued at $371.04 Billion in 2020 and is Anticipated to Reach $564.43 Billion in 2026
April 19, 2021 06:13 ET
|
Research and Markets
Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Others),...